Found: 101
Select item for more details and to access through your institution.
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 522, doi. 10.1159/000537915
- By:
- Publication type:
- Article
Network meta‐analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence.
- Published in:
- Liver International, 2024, v. 44, n. 10, p. 2763, doi. 10.1111/liv.16047
- By:
- Publication type:
- Article
Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence: a strategy to achieve R0 liver-sparing resection.
- Published in:
- Langenbeck's Archives of Surgery, 2022, v. 407, n. 4, p. 1741, doi. 10.1007/s00423-021-02409-0
- By:
- Publication type:
- Article
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice.
- Published in:
- Oncologist, 2008, v. 13, n. 12, p. 1270, doi. 10.1634/theoncologist.2008-0181
- By:
- Publication type:
- Article
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 7, p. 1562, doi. 10.3390/life13071562
- By:
- Publication type:
- Article
Surgery combined with intra-operative microwaves ablation for the management of colorectal cancer liver metastasis: A case-matched analysis and evaluation of recurrences.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1023301
- By:
- Publication type:
- Article
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.979519
- By:
- Publication type:
- Article
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5451, doi. 10.3390/cancers15225451
- By:
- Publication type:
- Article
Abdominal Visceral-to-Subcutaneous Fat Volume Ratio Predicts Survival and Response to First-Line Palliative Chemotherapy in Patients with Advanced Gastric Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5391, doi. 10.3390/cancers15225391
- By:
- Publication type:
- Article
Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Resection for Colorectal Liver Metastases at the Hepatocaval Confluence.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4683, doi. 10.3390/cancers15194683
- By:
- Publication type:
- Article
Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2200, doi. 10.3390/cancers15082200
- By:
- Publication type:
- Article
Editorial for Special Issue "Perspectives of Immunotherapy in Tumors of the Gastrointestinal Tract".
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 900, doi. 10.3390/cancers15030900
- By:
- Publication type:
- Article
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 381, doi. 10.3390/cancers15020381
- By:
- Publication type:
- Article
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5834, doi. 10.3390/cancers14235834
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 4974, doi. 10.3390/cancers14204974
- By:
- Publication type:
- Article
Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4896, doi. 10.3390/cancers14194896
- By:
- Publication type:
- Article
The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184453
- By:
- Publication type:
- Article
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1022, doi. 10.3390/cancers12041022
- By:
- Publication type:
- Article
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 247, doi. 10.1186/1471-2407-11-247
- By:
- Publication type:
- Article
Identification of Responders to Sorafenib in Hepatocellular Carcinoma: Is Tumor Volume Measurement the Way Forward?
- Published in:
- Oncology, 2014, v. 86, n. 4, p. 191, doi. 10.1159/000358599
- By:
- Publication type:
- Article
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 75, doi. 10.1159/000329079
- By:
- Publication type:
- Article
5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2001, v. 61, n. 1, p. 28, doi. 10.1159/000055349
- By:
- Publication type:
- Article
Oral Doxifluridine in Advanced Hepatocellular Carcinoma: A Phase II Study.
- Published in:
- Oncology, 2000, v. 59, n. 3, p. 204, doi. 10.1159/000012162
- By:
- Publication type:
- Article
Infusions of Fluorouracil and Leucovorin: Effects of the Timing and Semi-Intermittency of Drug Delivery.
- Published in:
- Oncology, 1999, v. 57, n. 3, p. 195, doi. 10.1159/000012031
- By:
- Publication type:
- Article
Use of a new cold plasma tool for psoriasis treatment: A case report.
- Published in:
- SAGE Open Medical Case Reports, 2020, v. 8, p. 1, doi. 10.1177/2050313X20922709
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1895, doi. 10.1002/onco.13886
- By:
- Publication type:
- Article
FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 302, doi. 10.1002/onco.13642
- By:
- Publication type:
- Article
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. 886, doi. 10.1634/theoncologist.2019-0922
- By:
- Publication type:
- Article
Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1178, doi. 10.1634/theoncologist.2017-0573
- By:
- Publication type:
- Article
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 8, p. 988, doi. 10.1634/theoncologist.2016-0084
- By:
- Publication type:
- Article
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245635, doi. 10.1001/jamanetworkopen.2024.5635
- By:
- Publication type:
- Article
Application of the ESR iGuide clinical decision support system to the imaging pathway of patients with hepatocellular carcinoma and cholangiocarcinoma: preliminary findings.
- Published in:
- La Radiologia Medica, 2020, v. 125, n. 6, p. 531, doi. 10.1007/s11547-020-01142-w
- By:
- Publication type:
- Article
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
- Published in:
- 2017
- By:
- Publication type:
- journal article
IL PAZIENTE ONCOLOGICO E I MECCANISMI DI CARDIOTOSSICITÀ.
- Published in:
- Outpatient Cardiology / Cardiologia Ambulatorial, 2023, v. 31, n. 2, p. 93, doi. 10.17473/1971-6818-2023-2-2
- By:
- Publication type:
- Article
Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian Center.
- Published in:
- In Vivo, 2020, v. 34, n. 4, p. 2061, doi. 10.21873/invivo.12008
- By:
- Publication type:
- Article
Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 1, p. 21, doi. 10.1093/jnci/djq456
- By:
- Publication type:
- Article
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database.
- Published in:
- International Journal of Biological Markers, 2015, v. 30, n. 1, p. e65, doi. 10.5301/jbm.5000117
- By:
- Publication type:
- Article
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 7, p. 1391, doi. 10.1038/s41416-023-02180-7
- By:
- Publication type:
- Article
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 957, doi. 10.1038/s41416-022-01852-0
- By:
- Publication type:
- Article
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
- Published in:
- 2022
- By:
- Publication type:
- journal article
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 3, p. 363, doi. 10.1007/s10147-023-02295-0
- By:
- Publication type:
- Article
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060892
- By:
- Publication type:
- Article
Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 6, p. 1, doi. 10.1007/s12032-024-02370-0
- By:
- Publication type:
- Article